Search Results - "ALSINA, Jeroni"

Refine Results
  1. 1

    Influence of nephron mass in development of chronic renal failure after prolonged warm renal ischemia by Cruzado, J M, Torras, J, Riera, M, Herrero, I, Hueso, M, Espinosa, L, Condom, E, Lloberas, N, Bover, J, Alsina, J, Grinyó, J M

    “…The present study examined the long-term consequences of warm renal ischemia (WRI) with or without renal ablation. Male Sprague-Dawley rats (250-300 g) were…”
    Get more information
    Journal Article
  2. 2

    Do Alloreactivity and Prolonged Cold Ischemia Cause Different Elementary Lesions in Chronic Allograft Nephropathy? by Herrero-Fresneda, Immaculada, Torras, Joan, Cruzado, Josep M., Condom, Enric, Vidal, August, Riera, Marta, Lloberas, Nuria, Alsina, Jeroni, Grinyo, Josep M.

    Published in The American journal of pathology (2003)
    “…This study assesses the individual contributions of the nonalloreactive factor, cold ischemia (CI), and alloreactivity to late functional and structural renal…”
    Get full text
    Journal Article
  3. 3

    Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients by MORESO, F, SERON, D, GIL-VERNET, S, RIERA, L, FULLADOSA, X, RAMOS, R, ALSINA, J, GRINYO, J. M

    Published in Nephrology, dialysis, transplantation (01-04-1999)
    “…Transplant recipients of kidneys harvested from old donors have a high incidence of delayed graft function (DGF) and a poor graft outcome. This result is…”
    Get full text
    Journal Article
  4. 4

    Early protocol renal allograft biopsies and graft outcome by Serón, Daniel, Moreso, Francesc, Bover, Jordi, Condom, Enric, Gil-Vernet, Salvador, Cañas, Conxa, Fulladosa, Xavier, Torras, Joan, Carrera, Marta, Grinyó, Josep Maria, Alsina, Jeroni

    Published in Kidney international (01-01-1997)
    “…Early protocol renal allograft biopsies and graft outcome. To evaluate whether biopsies performed early after transplantation in stable grafts can predict…”
    Get full text
    Journal Article
  5. 5

    Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy by SERON, D, MORESO, F, GRINYO, J. M, RAMON, J. M, HUESO, M, CONDOM, E, FULLADOSA, X, BOVER, J, GIL-VERNET, S, CASTELAO, A. M, ALSINA, J

    Published in Transplantation (15-05-2000)
    “…The minimum sample size to perform a clinical trial aimed to modify the natural history of chronic allograft nephropathy (CAN) is very large. Since the…”
    Get full text
    Journal Article
  6. 6

    Serial Protocol Biopsies to Quantify the Progression of Chronic Transplant Nephropathy in Stable Renal Allografts by Moreso, Francesc, Lopez, Marta, Vallejos, Augusto, Giordani, Cora, Riera, Lluís, Fulladosa, Xavier, Hueso, Miguel, Alsina, Jeroni, Grinyó, Josep M., Serón, Daniel

    Published in American journal of transplantation (01-05-2001)
    “…Aim: To evaluate the utility of intimal thickness and interstitial width as a primary efficacy variable in the design of clinical trials aimed to modify the…”
    Get full text
    Journal Article
  7. 7

    Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function by Hueso, M, Bover, J, Serón, D, Gil-Vernet, S, Sabaté, I, Fulladosa, X, Ramos, R, Coll, O, Alsina, J, Grinyó, J M

    Published in Transplantation (27-12-1998)
    “…Cyclosporine (CsA) nephrotoxicity can be identified by functional changes and chronic renal damage. CsA-associated renal fibrosis has been related to the…”
    Get full text
    Journal Article
  8. 8

    Recipient body surface area as a predictor of posttransplant renal allograft evolution by MORESO, F, SERON, D, ANUNCIADA, A. I, HUESO, M, RAMON, J. M, FULLADOSA, X, GIL-VERNET, S, ALSINA, J, GRINYO, J. M

    Published in Transplantation (15-03-1998)
    “…The aim of the present study was to analyze whether minor differences in recipient body surface area have any predictive value on renal allograft evolution…”
    Get full text
    Journal Article
  9. 9

    Treatment of hypertension after renal transplantation: Long-term efficacy of verapamil, enalapril, and doxazosin by Martínez-Castelao, Alberto, Hueso, Miquel, Sanz, Verónica, Rejas, Javier, Alsina, Jeroni, Grinyó, Josep M.

    Published in Kidney international (01-12-1998)
    “…Treatment of hypertension after renal transplantation: Long-term efficacy of verapamil, enalapril, and doxazosin. Normal blood pressure is a good marker of…”
    Get full text
    Journal Article
  10. 10

    Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts by Cruzado, J M, Gil-Vernet, S, Ercilla, G, Seron, D, Carrera, M, Bas, J, Torras, J, Alsina, J, Grinyó, J M

    “…In renal transplantation, chronic allograft nephropathy is the leading cause of long-term graft losses, transplant glomerulopathy being its glomerular form…”
    Get full text
    Journal Article
  11. 11

    Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipients by GRINYO, J. M, GIL-VERNET, S, SERON, D, CRUZADO, J. M, MORESO, F, FULLADOSA, X, CASTELAO, A. M, TORRAS, J, HOOFTMAN, L, ALSINA, J

    Published in Transplantation (15-06-1997)
    “…Acute rejection is an inherent risk of the withdrawal of steroids in renal allograft recipients. Mycophenolate mofetil is a potent immunosuppressant that, when…”
    Get full text
    Journal Article
  12. 12

    Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation by HERRERO, I, TORRAS, J, GRINYO, J. M, RIERA, M, CONDOM, E, COLL, O, CRUZADO, J. M, HUESO, M, BOVER, J, LLOBERAS, N, ALSINA, J

    Published in Nephrology, dialysis, transplantation (01-04-1999)
    “…Endothelin (ET) is known to play a role in the pathogenesis of warm ischaemic renal damage, however, little is known about its involvement in renal cold…”
    Get full text
    Journal Article
  13. 13

    Cold ischemia in the absence of alloreactivity induces chronic transplant nephropathy through a process mediated by the platelet-activating factor by HERRERO-FRESNEDA, Immaculada, TORRAS, Joan, LLOBERAS, Nuria, RIERA, Marta, CRUZADO, Josep M, CONDOM, Enric, MERLOS, Manel, ALSINA, Jeroni, GRINYO, Josep M

    Published in Transplantation (15-12-2000)
    “…Ischemia-reperfusion injury is considered a risk factor for the development of chronic transplant nephropathy (CTN) although the mechanisms that mediate its…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft by GRINYO, J. M, GIL-VERNET, S, CASTELAO, A. M, ALSINA, J, SERON, D, HUESO, M, FULLADOSA, X, CRUZADO, J. M, MORESO, F, FERNANDEZ, A, TORRAS, J, RIERA, L

    Published in Nephrology, dialysis, transplantation (01-10-1998)
    “…In renal transplantation the beneficial immunosuppressive effects of cyclosporin (CsA) may be curtailed by its nephrotoxicity, specially in patients receiving…”
    Get full text
    Journal Article
  16. 16

    A good alternative to reduce the kidney shortage : Kidneys from nonheartbeating donors by GONZALEZ-SEGURA, C, CASTELAO, A. M, TORRAS, J, MORESO, F, RIERA, L, LOPEZ-COSTEA, M. A, PASCUAL, M, GRINYO, J. M, ALSINA, J

    Published in Transplantation (15-06-1998)
    “…Because of the shortage of kidneys available for transplantation, we began in 1985 to harvest kidneys from non-heartbeating (NHB) donors. We compared the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients by Martínez-Castelao, Alberto, Grinyó, Josep M., Fiol, Concepció, Castiñeiras, María J., Hurtado, Isabel, Gil-Vernet, Salvador, Serón, Daniel, Porta, Isidre, Miñarro, Antonio, Villarroya, Angel, Alsina, Jeroni

    Published in Kidney international (01-07-1999)
    “…Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients. Hyperlipidemia contributes to the development and…”
    Get full text
    Journal Article
  19. 19
  20. 20